The multiple myeloma care team at Winship is recognized as a national and international leader in the research and comprehensive treatment of the disease. In the past ten years, their multiple myeloma experts have helped pioneer new drug therapies that have doubled the life expectancy of patients, and they are dedicated to building on that success.
As a patient at Winship, you have access to some of the world's leading myeloma experts and to a healthcare team that provides the highest standard of care, the newest clinical trials available and the most up-to-date approaches in managing myeloma. Their award-winning team has been recognized for their demonstrated leadership in, and exceptional contributions to, the development of recently FDA-approved drugs to treat multiple myeloma.
Winship offers you a comprehensive treatment plan customized for your disease by giving you access to genetic testing, molecular sequencing and expert assessment. With a multidisciplinary team that includes physicians, physician assistants, pathologists, radiologists, advanced practice nurses, oncology nurses and social workers, their aim is to be a resource at every stage of treatment in order to provide you with guidance on how to have the best long term survival with good quality of life.
The Emory team's approach to care offers a number of benefits to you, including:
The specialists at Winship also see patients with monoclonal gammopathy of undetermined significance (MGUS), smoldering myeloma or high-risk myeloma which are precancerous conditions and can become multiple myeloma.
Because of ground-breaking research and clinical trials at Winship and elsewhere, treatments for multiple myeloma are changing every day.
Winship’s doctors and researchers are studying the genetic components of multiple myeloma and using that knowledge to come up with better, more targeted drugs and individualized therapies.
The goal of controlling multiple myeloma as a chronic disease, or even curing it, is within reach.
Your treatment options will be tailored to your diagnosis based on the stage of your multiple myeloma and other factors such as lifestyle, age, and general health.
Chemotherapy: Multiple myeloma is sensitive to different combinations of chemotherapy, which may involve one or a combination of anticancer drugs that destroy cancer cells.
Bone Marrow and Stem Cell Transplantation: This treatment consists of destroying cancerous bone marrow cells by using higher doses of chemotherapy and in some cases, radiotherapy, and then replacing them with healthy bone marrow or stem cells to help patients regain a new and healthy immune system. Winship has pioneered many advances in bone marrow transplant procedures and drugs.
Targeted drugs and combination therapies: Recently, the U.S. FDA approved a number of new drugs that use the patient's immune system to fight multiple myeloma. Winship has pioneered the use of these drugs in combination with front-line therapies.
In addition to delivering the highest quality medical care, we recognize the importance of the psychological and emotional aspects of living with a cancer diagnosis and of dealing with treatment. Our supportive oncology team addresses these issues in a timely manner with additional support from counselors, nurse navigators, dietitians and social service professionals.
If you have been diagnosed with multiple myeloma, they are ready to help you.
See below to view contact information and call their team to make an appointment or request an appointment online. Winship experts are available to provide a second opinion.
We understand that this is a very stressful time. They welcome your questions and requests for help. Here is more information to help familiarize you with Winship and give you an idea of what to expect on your first visit.
The following is a list of myeloma clinical trials at this center.
View all active clinical trials around the US.
The following is a listing of clinical trials for patients with multiple myeloma who have been newly diagnosed or have not yet received treatment.
The following is a listing of clinical trials for patients with multiple myeloma who have received one to two prior lines of therapy.
The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.
The following is a listing of clinical trials for patients with Smoldering Myeloma.
The following is a listing of clinical trials for patients with Monoclonal Gammopathy of Undetermined Significance (MGUS).
For reliable, in-depth information about cancer symptoms, staging and diagnosis, visit CancerQuest, an educational and outreach program at Emory University.
SparkCures is working closely with Winship Cancer Institute of Emory University to provide the most up-to-date information on their myeloma program, specialists and clinical trials. Use the buttons above to claim this as your Home Center or add it to your List of Favorites.
Learn more about how we work with myeloma centers